Artiva Biotherapeutics (ARTV) Return on Sales (2023 - 2024)
Artiva Biotherapeutics (ARTV) has disclosed Return on Sales for 2 consecutive years, with 246.75% as the latest value for Q4 2024.
- Quarterly Return on Sales fell 25239.0% to 246.75% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 246.75% through Dec 2024, changed N/A year-over-year, with the annual reading at 260.45% for FY2024, 25959.0% down from the prior year.
- Return on Sales for Q4 2024 was 246.75% at Artiva Biotherapeutics, down from 12.53% in the prior quarter.
- The five-year high for Return on Sales was 5.64% in Q4 2023, with the low at 246.75% in Q4 2024.